Terms: = Germ cell tumor AND APOBEC3B, ARP4, 9582, ENSG00000179750, DJ742C19_2, _phorbolin 3_, PHRBNL, FLJ21201, Q9UH17, bK150C2_2, APOBEC1L, ARCD3 AND Staging
2191 results:
1. Analysis of the relationship between MYCN gene and serum NSE and urinary VMA levels and neuroblastoma pathological features and prognosis.
Zhang H; He X; Miao Q; Li L; Song J; Jiang X
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):134-139. PubMed ID: 38678619
[TBL] [Abstract] [Full Text] [Related]
2. [Construction and Validation of Prediction Models of Risk Factors for Early Death in Patients With Metastatic Melanoma].
Li S; Li J; Yang Q; Yin C; Liu B
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):367-374. PubMed ID: 38645854
[TBL] [Abstract] [Full Text] [Related]
3. Impact of grade on workup of rectal neuroendocrine tumors: a retrospective cohort study : Grade impact on workup of rectal NETs.
Watanabe A; Rai S; Yip L; Brown CJ; Loree JM; Stuart HC
World J Surg Oncol; 2024 Apr; 22(1):98. PubMed ID: 38627724
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic nomograms for predicting long-term overall survival in spindle cell melanoma: a population-based study.
Lau WC; Huang L; Zheng X; Ming WK; Leong NC; Tak Wong Y; Yin Z; Yu H; Lyu J; Deng L
Front Endocrinol (Lausanne); 2024; 15():1260966. PubMed ID: 38572477
[TBL] [Abstract] [Full Text] [Related]
5. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
Stassen RC; Maas CCHM; van der Veldt AAM; Lo SN; Saw RPM; Varey AHR; Scolyer RA; Long GV; Thompson JF; Rutkowski P; Keilholz U; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ
Lancet Oncol; 2024 Apr; 25(4):509-517. PubMed ID: 38547894
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
[No Abstract] [Full Text] [Related]
7. Squamous cell carcinoma malignant transformation in mature cystic teratoma of the ovary: a case report and review of the literature.
Jafari-Nozad AM; Jahani N; Nazeri N
J Med Case Rep; 2024 Mar; 18(1):145. PubMed ID: 38523295
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.
Heo S; Park HJ; Kim HJ; Kim JH; Park SY; Kim KW; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
Cancer Imaging; 2024 Feb; 24(1):28. PubMed ID: 38395973
[TBL] [Abstract] [Full Text] [Related]
9. Plain language summary of the CheckMate 76K study results: nivolumab given after stage 2B/2C melanoma is removed by surgery.
Kirkwood JM; Vecchio MD; Weber J; Hoeller C; Grob JJ; Mohr P; Loquai C; Dutriaux C; Chiarion-Sileni V; Mackiewicz J; Rutkowski P; Arenberger P; Quereux G; Meniawy TM; Ascierto PA; Menzies AM; Durani P; Lobo M; Campigotto F; Gastman B; Long GV
Future Oncol; 2024 May; 20(15):959-968. PubMed ID: 38390818
[TBL] [Abstract] [Full Text] [Related]
10. Diagnosis and staging of small intestinal neuroendocrine tumors with CT enterography and PET with Gallium-68: preoperative risk stratification protocol.
Bonomi A; Fumagalli Romario U; Funicelli L; Conti G; Realis Luc M; Ceci F; Pozzi S; Radice D; Fazio N; Bertani E
Langenbecks Arch Surg; 2024 Feb; 409(1):63. PubMed ID: 38363374
[TBL] [Abstract] [Full Text] [Related]
11. Combined visual and quantitative assessment of somatostatin receptor scintigraphy for staging and restaging of neuroendocrine tumors.
Ueki Y; Otsuka H; Otani T; Kasai R; Otomi Y; Ikemitsu D; Azane S; Kunikane Y; Bando T; Matsuda N; Okada Y; Takayama T; Harada M
Jpn J Radiol; 2024 May; 42(5):519-535. PubMed ID: 38345724
[TBL] [Abstract] [Full Text] [Related]
12. Impact of extra-nodal extension and AJCC lymph node staging in predicting recurrence following lymphadenectomy in patients with melanoma.
Downey J; Hamm J; Baliski C
Am J Surg; 2024 May; 231():120-124. PubMed ID: 38320886
[TBL] [Abstract] [Full Text] [Related]
13. Survival impact of post-operative immunotherapy in resected stage III cutaneous melanomas in the checkpoint era.
Hagopian G; Jiang X; Grant C; Brazel D; Kumar P; Yamamoto M; Jakowatz J; Chow W; Tran T; Shen W; Moyers J
ESMO Open; 2024 Feb; 9(2):102193. PubMed ID: 38271786
[TBL] [Abstract] [Full Text] [Related]
14. Pineal anlage tumor: clinical and diagnostic features, and rationales for treatment.
Obrecht-Sturm D; Pfaff E; Mynarek M; Bison B; Rodehüser M; Becker M; Kietz S; Pfister SM; Jones DT; Sturm D; von Deimling A; Sahm F; Kortmann RD; Schwarz R; Pietsch T; Fleischhack G; Rutkowski S
J Neurooncol; 2024 Jan; 166(2):359-368. PubMed ID: 38253790
[TBL] [Abstract] [Full Text] [Related]
15. Retinoblastoma treatment in a Brazilian population. Presentation and long-term results.
Bonanomi MTBC; de Almeida MTA; Hollaender MA; Bonanomi RC; Monteiro MLR
Cancer Med; 2024 Feb; 13(3):e6683. PubMed ID: 38243643
[TBL] [Abstract] [Full Text] [Related]
16. Simultaneous melanomas in the setting of multiple primary melanomas.
Kostaki M; Plaka M; Befon A; Dessinioti C; Kypraiou K; Chardalia V; Christofidou E; Polydorou D; Stratigos A
Melanoma Res; 2024 Apr; 34(2):198-201. PubMed ID: 38224405
[TBL] [Abstract] [Full Text] [Related]
17. The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix.
Zhao D; Sun S; Yang Z; Wang P; Qiu H
Neoplasma; 2024 Feb; 71(1):70-76. PubMed ID: 38215035
[TBL] [Abstract] [Full Text] [Related]
18. Diagnostic value of [ 68 Ga]Ga-Pentixafor PET/CT in malignant melanoma: a pilot study.
Manafi-Farid R; Mahini M; Mirshahvalad SA; Fallahi B; Fard-Esfahani A; Emami-Ardekani A; Eftekhari M; Mousavi SA; Beiki D
Nucl Med Commun; 2024 Mar; 45(3):221-228. PubMed ID: 38214076
[TBL] [Abstract] [Full Text] [Related]
19. Impact of sex on treatment decisions and outcome in patients with neuroendocrine neoplasms.
Beck J; Siebenhüner A; Wild D; Christ E; Refardt J
Endocr Relat Cancer; 2024 Mar; 31(3):. PubMed ID: 38117915
[TBL] [Abstract] [Full Text] [Related]
20. Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs.
Vasta FM; Cormio G; Cassani C; Bergamini A; Scarfone G; Ferrandina G; De Vivo R; Marinaccio M; Danese S; Raspagliesi F; Pignata S; Mangili G
Gynecol Oncol; 2024 Feb; 181():28-32. PubMed ID: 38104526
[TBL] [Abstract] [Full Text] [Related]
[Next]
